Guest guest Posted April 6, 2005 Report Share Posted April 6, 2005 Most people stopped paying attention to Epstein Barr when researchers concluded it wasn't the cause of chronic fatigue syndrome. I have Lyme, and a few other diagnoses. One of the lab findings was an elevated titer for the early antigen to EBV. This was flagged by the lab as possibly indicating 'chronic, reactivated infection.' So now I'm taking a second look at EBV, not as a primary culprit but as a chronic co-infection, with possible symptomatic relevance and implications for how my immune system is coping (or NOT coping) with Lyme. I found this Pub Med citation, thought it was worth posting: J Infect Dis. 2005 Feb 15;191(4):531-9. Epub 2005 Jan 6. Related Articles, Links Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. Kimura H, Hoshino Y, Hara S, Sugaya N, Kawada J, Shibata Y, Kojima S, Nagasaka T, Kuzushima K, Morishima T. Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. hkimura@... Infections of T cells and natural killer (NK) cells play a central role in the pathogenesis of chronic active Epstein-Barr virus (CAEBV) infection. To characterize the virologic and cytokine profiles of T cell-type and NK cell-type infection, 39 patients with CAEBV infection were analyzed. Patients with T cell-type infection had higher titers of immunoglobulin G against early and late EBV antigens, suggesting lytic cycle infection. However, the pattern of EBV gene expression was latency type II; BZLF1, which is a hallmark of lytic cycle infection, could not be detected in any patients, regardless of infection type. Patients with CAEBV infection had high concentrations of proinflammatory, T helper cell type 1, and anti-inflammatory cytokines. The cytokine profile in patients with NK cell-type infection was similar to that in patients with T cell-type infection, but the concentration of IL-13 was high in patients with NK cell-type infection. These findings should help to clarify the pathogenesis of CAEBV infection and facilitate the development of more-effective treatments. PMID: 15655776 [PubMed - indexed for MEDLINE] Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.